Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Immune Response describes herpes vaccine research at FASEB 99

April 19, 1999

Compounds and methods for treating or diagnosing leishmaniasis disclosed by Corixa

April 16, 1999

Epimmune publishes studies on hepatitis, malaria vaccine development

April 12, 1999

SangStat's ciclosporin capsules filed for approval in U.K.

April 12, 1999

Fujisawa and NeXstar team up to identify new immunological agents

April 12, 1999

Addition of Canadian sites to phase III WF-10 AIDS trial approved

April 12, 1999

LeIF adjuvant enhances therapeutic efficacy of leishmaniasis vaccine in humans

April 9, 1999

Stanford Rook establishes strategic research collaboration with Genesis

April 8, 1999

PowderJect presents positive data using PowderJect DNA vaccine

April 8, 1999

Aquila reveals new product in pipeline: CD1-TB

April 5, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...